Americans are unlikely to see generic versions of semaglutide — the active ingredient in Novo Nordisk’s Ozempic and Wegovy — until at least the end of 2031, according to a May 13 NBC News report. Novo ...

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Subscribe to read this story ad-free Get unlimited access to ...

Mortgage lenders are rushing to adopt AI, but many are repeating a familiar mistake: using new technology to accelerate old processes. Faster paper-pushing isn’t transformation. AI presents an ...

Here’s how to invest in custom visuals and turn that content into years of stronger engagement, trust and brand differentiation. Custom visual content builds trust faster by showing real people, ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

In “Why Do We Exist?” Hakeem Oluseyi explores how life may have emerged to move energy through matter—and why Earth is the perfect setting. The following is an excerpt from “Why Do We Exist?: The Nine ...

If it feels like lovebugs are suddenly everywhere in Houston, you’re not imagining it. “At school, during lunch, on the way to lines,” said Ayomie Ogune. “It’s a lot.” Experts say the surge is part of ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Scientists have long tried to decode every dream we have. Some say it’s survival training, ...

Winning the moon race back in the Cold War was a national security imperative — and was funded like it. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. Most of us, if we think about chins at all, do so rarely. But it turns out that chins ...

March 31 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off ...